Telehealth Service Returns 100% TB Treatment Adherence During Hurricane Harvey


The emocha Mobile Health program gave physicians remote access to tuberculosis patients.

Directly observed therapy (DOT) has become a crucial asset in caring for deadly, infectious diseases such as tuberculosis (TB). In fact, many US public health departments have made DOT a required practice for physicians and patients with TB.

Such is the case in Harris County, TX. According to the US Center for Disease Control and Prevention (CDC), the Texas Department of State Health Services (DSHS) uses public funding for TB surveillance, prevention, and control methods within 8 health service regions, 31 local health departments, and 4 binational TB projects.

When Hurricane Harvey passed through Dallas and Harris County at-large in late August, the Category 4 major hurricane forced week-long closures of several local health departments and displaced patients from their physicians.

telehealth, emocha, hurricane harvey, tuberculosis, infectious disease

According to a CDC Morbidity and Mortality Report, representatives from Texas reported a nearly perfect patient treatment adherence rate for TB medication in the Harris County region in that span of time — a rare feat regardless of weather conditions.

Baltimore, MD-based health technology company emocha Mobile Health provides video DOT technology that remotely allows physicians to check off on patients’ treatment adherence. One such program in Harris County had enrolled 61 patients with TB prior to the hurricane’s landfall.

Among that population, 59 (97%) were properly located and monitored, and not one of them missed any medication doses.

Sebastian Seiguer, chief executive officer of emocha, told MD Magazine that each patient was prescribed about a months’ worth of TB therapy prior to the hurricane. No doses were missed by the 59 located patients.

“I mean 100% — that’s a really big deal,” Seiguer said. “There are very, very few situations where you can accomplish such a number. That’s really a fantastic number.”

The emocha patient population were among 282 high-priority TB patients tracked by local and state officials during the hurricane. At the time, 30 had been diagnosed with TB, and 31 had latent TB infection.

The telehealth-based response to public health agencies affected by the storm came from lessons learned in previous hurricanes, according to the CDC’s report.

“Whereas approximately half of the TB patients in New Orleans, Louisiana, fled the state during Hurricane Katrina, TB patients in Texas during Hurricane Harvey typically remained close to their usual residence,” the report read.

Seiguer called Harris County public health system “pioneers in the system” of emocha, having used the service for over 3 years now. Though telehealth is often susceptible to more praise in the case of emergency situations, Seiguer credited Texas agencies for their preparedness.

“They had the same situation in late 2014, with flooding in the region,” Seiguer said. “Being prepared and being really excellent in regards of technology is what really sets you up for success in tough situations, and the state of Texas did a really great job here.”

Emocha’s asynchronous video DOT service has obvious benefits for patients with infectious disease: the remote surveillance of physicians ensures patients’ family members or loved ones do not have to aid or oversee treatment administration, and cause risks for either party. Though its advantages are doubly in the wake of weather emergencies, Seiguer imagines the technology can bolster even an asthma patient’s treatment adherence on a sunny day.

“In the really extreme situations, the necessity and the utility comes out,” Seiguer said. “But I think the rates of adherence across the board are low — whether it’s diabetes, asthma, hepatitis, tuberculosis. What we see with such a technology is the ability to take a technique, and scale it across the board.”

Aside from aiding in the wake of Hurricane Harvey, the emocha system has been used in ensuring remote DOT for patients undergoing opioid addiction therapy, and for gauging patients susceptible to the Ebola virus after visiting Africa during the 2014-15 outbreak, Seiguer said.

But he believes it could serve a larger purpose, noting that the US health care system spends about $400 billion annually on medicine, despite nonadherence issues.

“It saves a lot of time and resources for everyone involved,” Seiguer said.

Related Videos
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Cedric Rutland, MD: Exploring Immunology's Role in Molecule Development
Cedric Rutland, MD: Mechanisms Behind Immunology, Cellular Communication
Glenn S. Tillotson, PhD: Treating Immunocompromised Patients With RBX2660
Paul Feuerstadt, MD: Administering RBX2660 With a Colonoscopy
Jessica Allegretti, MD, MPH: Evaluating the First Few Months of RBX2660
Naim Alkhouri, MD: Improving NASH Diagnosis With FibroScan
© 2024 MJH Life Sciences

All rights reserved.